Although we cannot yet determine why two experiments measuring LPCAT3 expression in NASH mice yielded opposite results, it is certain that LPCAT3 expression is closely linked to the progression of NASH. Here, LPCAT3 is linked to metabolic dysfunction-associated steatohepatitis.